Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 open-label study of ganetespib in breast cancer
2012-000558-71Phase 2Completed
- Sponsor
- Synta Pharmaceuticals Corp.
- Start
- Apr 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ganetespib in breast cancer, sponsored by Synta Pharmaceuticals Corp.. Started Apr 2012; status: completed.
02
Drugs
ganetespib
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2012-000558-71.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000558-71.